The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice.
Open accessAbstract
We have previously shown that continuous administration of anti-interleukin 10 (anti-IL-10) antibodies (Abs) to BALB/c mice modifies endogenous levels of autoantibodies, tumor necrosis factor alpha (TNF-alpha), and interferon gamma, three immune mediators known to affect the development of autoimmunity in "lupus-prone" New Zealand black/white (NZB/W)F1 mice. To explore the consequences of IL-10 neutralization in NZB/W F1 mice, animals were injected two to three times per week from birth until 8-10 mo of age with anti-IL-10 Abs or with isotype control Abs. Anti-IL-10 treatment substantially delayed onset of autoimmunity in NZB/W F1 mice as monitored either by overall survival, or by development of proteinuria, glomerulonephritis, or autoantibodies. Survival at 9 mo was increased from 10 to 80% in anti-IL-10-treated mice relative to Ig isotype-treated controls. This protection against autoimmunity appeared to be due to an anti-IL-10-induced upregulation of endogenous TNF-alpha, since anti-IL-10-protected NZB/W F1 mice rapidly developed autoimmunity when neutralizing anti-TNF-alpha Abs were introduced at 30 wk along with the anti-IL-10 treatment. Consistent with the protective role of anti-IL-10 treatment in these experiments, continuous administration of IL-10 from 4 until 38 wk of age accelerated the onset of autoimmunity in NZB/W F1 mice. The same period of continuous IL-10 administration did not appear to be toxic to, or cause development of lupus-like autoimmunity in normal BALB/c mice. These data suggest that IL-10 antagonists may be beneficial in the treatment of human systemic lupus erythematosus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
Bottazzo, G., Hanafusa, T., Pujol-Borrell, R., & Feldmann, M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90629-3 · Cited by 1,256
The Immunology and Pathology of NZB Mice
(1968) · Advances in Immunology · doi:10.1016/s0065-2776(08)60444-7 · Cited by 660
Immune interferon: a pleiotropic lymphokine with multiple effects
Trinchieri, G., & Perussia, B. (1985) · Immunology Today · doi:10.1016/0167-5699(85)90080-5 · Cited by 658
Biological properties of interleukin 10
Howard, M., & O'Garra, A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90153-x · Cited by 640
Self-citationJacob, C. O., Fronek, Z., Lewis, G. D., Koo, M., Hansen, J. A., & McDevitt, H. O. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1233 · Cited by 627
Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis
Jacob, C. O., & McDevitt, H. O. (1988) · Nature · doi:10.1038/331356a0 · Cited by 596
Jacob, C. O., van der Meide, P. H., & McDevitt, H. O. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.3.798 · Cited by 386
Abrams, J. S., Roncarolo, M., Yssel, H., Andersson, U., Gleich, G. J., & Silver, J. E. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01406.x · Cited by 362
Biological properties of interleukin 10
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & De Vries, J. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918147 · Cited by 348
Self-citationNormal, Autoimmune, And Malignant Cd5+ B Cells: The Ly-1 B Lineage
Hayakawa, K., & Hardy, R. R. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.197 · Cited by 301
Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis.
Dunham, I., Sargent, C. A., Trowsdale, J., & Campbell, R. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7237 · Cited by 235
Mosmann, T. R., Schumacher, J. H., Fiorentino, D. F., Leverah, J., Moore, K. W., & Bond, M. W. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.9.2938 · Cited by 231
Wong, G. H. W., Clark-Lewis, I., McKimm-Breschkin, J. L., Harris, A. W., & Schrader, J. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.788 · Cited by 229
Müller, U., Jongeneel, C. V., Nedospasov, S. A., Lindahl, K. F., & Steinmetz, M. (1987) · Nature · doi:10.1038/325265a0 · Cited by 225
Ishida, H., Hastings, R., Kearney, J., & Howard, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1213 · Cited by 196
Self-citationChronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice
Gordon, C., Ranges, G. E., Greenspan, J. S., & Wofsy, D. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90157-8 · Cited by 167
Interferon treatment of NZB mice: accelerated progression of autoimmune disease
Heremans, H., Billiau, A., Colombatti, A., Hilgers, J., & Somer, P. D. (1978) · Infection and Immunity · doi:10.1128/iai.21.3.925-930.1978 · Cited by 128
Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities.
Berden, J. H. M., Hang, L., McConahey, P. J., & Dixon, F. J. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1699 · Cited by 112
Watanabe, Y., & Jacob, C. O. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.3.899 · Cited by 101
Effects of recombinant murine tumor necrosis factor- alpha on immune function.
Gordon, C., & Wofsy, D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.5.1753 · Cited by 85
Modified Immunological Status of Anti-IL-10 Treated Mice
Ishida, H., Hastings, R., Thompson-Snipes, L., & Howard, M. (1993) · Cellular Immunology · doi:10.1006/cimm.1993.1119 · Cited by 75
Self-citationJongeneel, C. V., Acha‐Orbea, H., & Blankenstein, T. J. F. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.6.2141 · Cited by 62
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
“However, IL-10-producing T cells are not always anti-inflammatory, and in some circumstances they have been shown to promote autoimmunit”
Background
Metadata
- Authors
- Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., & Howard, M.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1994-01-01
- Volume
- 179
- Issue
- 1
- Pages
- 305-310
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2121646580
- Cited by
- 532
- References
- 23
- FWCI
- 24.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.